中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
16期
3023-3028
,共6页
王忠明%廖辰%康亚辉%马建新%黄关宏%陈程%张建国%屠婷婷%刘小林
王忠明%廖辰%康亞輝%馬建新%黃關宏%陳程%張建國%屠婷婷%劉小林
왕충명%료신%강아휘%마건신%황관굉%진정%장건국%도정정%류소림
辐射性肺炎%转化生长因子β1%T淋巴细胞亚群%CD4+CD25+T细胞
輻射性肺炎%轉化生長因子β1%T淋巴細胞亞群%CD4+CD25+T細胞
복사성폐염%전화생장인자β1%T림파세포아군%CD4+CD25+T세포
Radiation pneumonitis%Transforming growth factor beta1%T-lymphocyte subsets%CD4+CD25+T cells
目的:研究放疗前后血清TNF-α、TGF-β1及 T淋巴细胞亚群水平与急性放射性肺病的关系。方法收集食管癌和非小细胞肺癌患者60例,采用ELISA法检测放疗前后血清TNF-α、TGF-β1水平,采用流式细胞术检测放疗前后T细胞亚群水平,并评价它们与急性放射性肺病之间的关系。结果(1)放疗后患者血清 TNF-α水平升高,但高损伤组(放射性肺病≥2级)与低损伤组(放射性肺病<2级)TNF-α水平无统计学差异。(2)放疗结束时和放疗结束后3个月高损伤组TGF-β1水平显著高于低损伤组[(13.06±5.24)ng/ml vs.(9.14±4.93)ng/ml,P=0.009;(10.88±4.95) ng/ml vs.(7.02±3.42)ng/ml,P=0.008]。(3)放疗结束时和放疗结束3个月高损伤组总T细胞水平显著低于低损伤组[(56.12±9.88)% vs.(66.88±14.27)%, P=0.007;(59.88±10.02)% vs.(66.98±10.21)%,P=0.019],但CD4+和CD8+T细胞水平均未显现出统计学差异。(4)放疗结束时和放疗结束后3个月高损伤组 CD4+CD25+T 细胞水平显著高于低损伤组[(17.81±3.87)% vs.(14.51±5.19)%,P=0.022;(16.39±3.78)%vs.(13.05±3.61)%,P=0.003]。(5)CD4+CD25+T细胞水平与TGF-β1水平之间存在一定的正相关性。结论放疗后TGF-β1升高、总T细胞降低及CD4+CD25+T细胞水平升高者,发生放射性肺损伤较明显,且TGF-β1与CD4+CD25+T细胞水平之间存在一定的正相关性。
目的:研究放療前後血清TNF-α、TGF-β1及 T淋巴細胞亞群水平與急性放射性肺病的關繫。方法收集食管癌和非小細胞肺癌患者60例,採用ELISA法檢測放療前後血清TNF-α、TGF-β1水平,採用流式細胞術檢測放療前後T細胞亞群水平,併評價它們與急性放射性肺病之間的關繫。結果(1)放療後患者血清 TNF-α水平升高,但高損傷組(放射性肺病≥2級)與低損傷組(放射性肺病<2級)TNF-α水平無統計學差異。(2)放療結束時和放療結束後3箇月高損傷組TGF-β1水平顯著高于低損傷組[(13.06±5.24)ng/ml vs.(9.14±4.93)ng/ml,P=0.009;(10.88±4.95) ng/ml vs.(7.02±3.42)ng/ml,P=0.008]。(3)放療結束時和放療結束3箇月高損傷組總T細胞水平顯著低于低損傷組[(56.12±9.88)% vs.(66.88±14.27)%, P=0.007;(59.88±10.02)% vs.(66.98±10.21)%,P=0.019],但CD4+和CD8+T細胞水平均未顯現齣統計學差異。(4)放療結束時和放療結束後3箇月高損傷組 CD4+CD25+T 細胞水平顯著高于低損傷組[(17.81±3.87)% vs.(14.51±5.19)%,P=0.022;(16.39±3.78)%vs.(13.05±3.61)%,P=0.003]。(5)CD4+CD25+T細胞水平與TGF-β1水平之間存在一定的正相關性。結論放療後TGF-β1升高、總T細胞降低及CD4+CD25+T細胞水平升高者,髮生放射性肺損傷較明顯,且TGF-β1與CD4+CD25+T細胞水平之間存在一定的正相關性。
목적:연구방료전후혈청TNF-α、TGF-β1급 T림파세포아군수평여급성방사성폐병적관계。방법수집식관암화비소세포폐암환자60례,채용ELISA법검측방료전후혈청TNF-α、TGF-β1수평,채용류식세포술검측방료전후T세포아군수평,병평개타문여급성방사성폐병지간적관계。결과(1)방료후환자혈청 TNF-α수평승고,단고손상조(방사성폐병≥2급)여저손상조(방사성폐병<2급)TNF-α수평무통계학차이。(2)방료결속시화방료결속후3개월고손상조TGF-β1수평현저고우저손상조[(13.06±5.24)ng/ml vs.(9.14±4.93)ng/ml,P=0.009;(10.88±4.95) ng/ml vs.(7.02±3.42)ng/ml,P=0.008]。(3)방료결속시화방료결속3개월고손상조총T세포수평현저저우저손상조[(56.12±9.88)% vs.(66.88±14.27)%, P=0.007;(59.88±10.02)% vs.(66.98±10.21)%,P=0.019],단CD4+화CD8+T세포수평균미현현출통계학차이。(4)방료결속시화방료결속후3개월고손상조 CD4+CD25+T 세포수평현저고우저손상조[(17.81±3.87)% vs.(14.51±5.19)%,P=0.022;(16.39±3.78)%vs.(13.05±3.61)%,P=0.003]。(5)CD4+CD25+T세포수평여TGF-β1수평지간존재일정적정상관성。결론방료후TGF-β1승고、총T세포강저급CD4+CD25+T세포수평승고자,발생방사성폐손상교명현,차TGF-β1여CD4+CD25+T세포수평지간존재일정적정상관성。
Objective To detect the levels of serum TNF-α, TGF-β1 and T lymphocyte subsets before and after radiotherapy and evaluate their clinical relevance in radiation pneumopathy (RP). Methods 60 patients with esophageal cancer or non-small cell lung cancer were collected in Lianyungang NO.2 Hospital from November, 2011 to July, 2012. Serum levels of TNF-α and TGF-β1 were detected by enzyme linked immunosorbent assay (ELISA) and the proportion of T lymphocyte subsets was analyzed by flow cytometry (FCM) before and after radiotherapy. The relationship between them and RP was analyzed. Results (1)TNF-α levels were increased after radiotherapy, but there was no significant differences between RP group (RP grade≥2) and non-RP group (RP grade<2). (2)TGF-β1 levels in RP group were significantly higher than that in non-RP group at the end of radiotherapy and 3 months after radiotherapy, (13.06±5.24)ng/ml vs. (9.14±4.93)ng/ml, P=0.009; (10.88±4.95)ng/ml vs. (7.02±3.42)ng/ml, P=0.008.(3)The proportion of T lymphocytes in RP group was significantly lower than that in non-RP group at the end of radiotherapy and 3 months after radiotherapy, (56.12±9.88)% vs. (66.88±14.27)%, P=0.007;(59.88±10.02)%vs. (66.98±10.21)%, P=0.019, but there was no significant differences in the proportion of CD4+T cells and CD8+T cells. (4)The proportion of CD4+CD25+T cells in RP group was significantly higher than that in non-RP group at the end of radiotherapy and 3 months after radiotherapy, (17.81±3.87)%vs. (14.51±5.19)%, P=0.022;(16.39±3.78)%vs. (13.05±3.61)%, P=0.003. (5)There was a positive correlation between TGF-β1 level and the proportion of CD4+CD25+T cells. Conclusion The serum level of TGF-β1 and the proportion of T lymphocytes and CD4+CD25+T cells could identify patients at risk for RP. There is a positive correlation between TGF-β1 level and the proportion of CD4+CD25+T cells.